Adrenocortical tumors, primary pigmented adrenocortical disease (PPNAD)/Carney complex, and other bilateral hyperplasias: The NIH studies

Hormone and Metabolic Research

Volumn 39, Issue 6, 2007, Pages 467-473

  Stratakis, C A ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Adrenal cortex genetics; Carney complex; Hyperplasias; Primary pigmented adrenocortical disease (PPNAD); Tumor

Indexed keywords

PHOSPHODIESTERASE; PHOSPHODIESTERASE XIA; UNCLASSIFIED DRUG;

ADRENAL CORTEX TUMOR; ADRENAL HYPERPLASIA; AUTOPSY; BENIGN TUMOR; CARCINOGENESIS; CARCINOMA; CARNEY COMPLEX; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DELAYED DIAGNOSIS; DEPRESSION; DIABETES MELLITUS; DISEASE PREDISPOSITION; ENDOCRINE DISEASE; GENE; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE; HEALTH CARE ORGANIZATION; HUMAN; HYPERTENSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INCIDENTALOMA; MALIGNANT TRANSFORMATION; METABOLIC SYNDROME X; MOLECULAR BIOLOGY; MOLECULAR GENETICS; MORBIDITY; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; OSTEOPOROSIS; PATHOLOGY; PDE11A GENE; PRIMARY PIGMENTED ADRENOCORTICAL DISEASE; PRIORITY JOURNAL; TP53 GENE; TUMOR VOLUME;

ADRENAL CORTEX; ADRENAL CORTEX DISEASES; ADRENAL CORTEX NEOPLASMS; GENES, P53; HUMANS; HYPERPLASIA; MUTATION; PHOSPHORIC DIESTER HYDROLASES; PIGMENTATION DISORDERS;

EID: 34347213389     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-981477     Document Type: Conference Paper

References (97)

1. Orth DN, Kovacs WJ, DeBold CR. The adrenal cortex. In: Wilson JD, Foster DW (eds). Williams Textbook of Endocrinology. Philadelphia: W. B. Sauders, 1992
2. Gaunt R. History of the adrenal cortex. In: Creep RO, Astwood EB (eds). Handbook of physiology. Sect. 7: Endocrinology. Vol VI Adrenal gland. Washington DC: American Physiological Society, 1975
3. Latronico AC, Chrousos GP. Extensive personal experience: adrenocortical tumors. J Clin Endocrinol Metab 1997; 82: 1317-1324
4. Ross NS, Aron DC. Hormonal evaluation of the patient with an incidentally discovered adrenal mass. N Engl J Med 1990; 323: 1401-1405
5. Kloos RT, Gross MD, Francis IR, Korobkin M, Shapiro B. Incidentally discovered adrenal masses. Endocr Rev 1995; 16: 460-484
6. King DR, Lack EE. Adrenal cortical carcinoma: a clinical and pathologic study of 49 cases. Cancer 1979; 44: 239-244
7. Lee JE, Evans DB, Hickey RC, Sherman SI, Gagel RF, Abbruzzese MC, Abbruzzese JL. Unknown primary cancer presenting as an adrenal mass: frequency and implications for diagnostic evaluation of adrenal incidentalomas. Surgery 1998; 124: 1115-1122
8. Cagel PT, Hough AJ, Fysher TJ. Comparison of adrenal cortical tumors in children and adults. Cancer 1986; 57: 2235-2237
9. Didolkar MS, Bescher RA, Elias EG et al. Natural history of adrenal cortical carcinoma:a clinicopathologic study of 42 patients. Cancer 1981; 47: 2153-2161
10. Demeure MJ, Somberg LB. Functioning and nonfunctioning adrenocortical carcinoma: clinical presentation and therapeutic strategies. Surg Oncol Clin N Am 1998; 7: 791-805
11. Terzolo M, Ali A, Osella G, Mazza E. Prevalence of adrenal carcinoma among incidentally discovered adrenal masses. A retrospective study from 1989 to 1994. Gruppo Piemontese Incidentalomi Surrenalici. Arch Surg 1997; 132: 914-919
12. Kasperlik-Zaluska AA, Migdalska BM, Makowska AM. Incidentally found adrenocortical carcinoma. A study of 21 patients. Eur J Cancer 1998; 34: 1721-1724
13. Sandrini R, Ribeiro RC, DeLacerda L. Childhood adrenocortical tumors. J Clin Endocrinol Metab 1997; 82: 2027-2031
14. Skogseid B, Rastad J, Gobi A et al. Adrenal lesion in multiple endocrine neoplasia type 1. Surgery 1995; 118: 1077-1082
15. Marchesa P, Fazio VW, Church JM, McGannon E. Adrenal masses in patients with familial adenomatous polyposis. Dis Colon Rectum 1997; 40: 1023-1028
16. Stratakis CA, Chrousos GP. In: Endocrine Tumors. Pizzo PA, Poplack DG (eds). Principles and Practice of Pediatric Oncology. Philadelphia PA: Lippincott-Raven Publishers, 1997; 947-976
17. Mayer SK, Oligny LL, Deal C, Yazbeck S, Gagne N, Blanchard H. Childhood adrenocortical tumors: case series and reevaluation of prognosis - a 24-year experience. J Pediatr Surg 1997; 32: 911-915
18. Teinturier C, Pauchard MS, Brugieres L, Landais P, Chaussain JL, Bougneres PF. Clinical and prognostic aspects of adrenocortical neoplasms in childhood. Med Pediatr Oncol 1999; 32: 106-111
19. Bornstein S, Stratakis CA, Chrousos GP. Recent advances in adrenocortical tumors. Ann Intern Med 1999; 759-771
20. Beuschlein F, Reincke M, Karl M et al. 1994 Clonal composition of human adrenocortical neoplasms. Cancer Res 1994; 54: 4927-4932
21. Latronico AC, Reincke M, Mendonca BB et al. No evidence for oncogenic mutations in the adrenocorticotropin receptor gene in human adrenocortical neoplasms. J Clin Endocrinol Metab 1995; 80: 875-877
22. Reincke M, Mora P, Beuschlein F, Arlt W, Chrousos GP, Allolio B. Deletion of the adrenocorticotropin receptor gene in human adrenocortical tumors: implications for tumorigenesis. J Clin Endocrinol Metab 1997; 82: 3054-3058
23. Reincke M, Karl M, Travis W, Chrousos GP. No evidence for oncogenic mutations in guanine nucleotide-binding proteins of human adrenocortical neoplasms. J Clin Endocrinol Metab 1993; 77: 1419-1422
24. Lyons J, Landis CA, Harsh G et al. Two G protein oncogenes in human endocrine tumors. Science 1990; 249: 655-659
25. Reincke M. Mutations in adrenocortical tumors. Horm Metab Res 1998; 30: 447-455
26. Boston BA, Mandel S, LaFranchi S, Bliziotes M. Activating mutation in the stimulatory guanine nucleotide-binding protein in an infant with Cushing's syndrome and nodular adrenal hyperplasia. J Clin Endocrinol Metab 1994; 79: 890-893
27. Beuschlein F, Schulze E, Mora P et al. Steroid 21-hydroxylase mutations and 21-hydroxylase messenger ribonucleic acid expression in human adrenocortical tumors. J Clin Endocrinol Metab 1998; 83: 2585-2588
28. Tanabe A, Naruse M, Arai K et al. Gene expression and roles of angiotensin II type 1 and type 2 receptors in human adrenals. Horm Metab Res 1998; 30: 490-495
29. Gortz B, Roth J, Speel EJ et al. MEN1 gene mutation analysis of sporadic adrenocortical lesions. Int J Cancer 1999; 80: 373-379
30. Heppner C, Reincke M, Agarwal SK et al. MEN1 gene analysis in sporadic adrenocortical neoplasms. J Clin Endocrinol Metab 1999; 84: 216-219
31. Wakatsuki S, Sasano H, Matsui T et al. Adrenocortical tumor in a patient with familial adenomatous polyposis: a case associated with a complete inactivating mutation of the APC gene and unusual histologic features. Hum Pathol 1998; 29: 302-306
32. Marx C, Bornstein SR, Wotkersdorfer GT, Peter M, Sippell WG, Scherbaum WA. Relevance of major histocompatibility complex class II expression as a hallmark for the cellular differentiation in the human adrenal cortex. J Clin Endocrinol Metab 1997; 82: 3136-3140
33. Sasano H, Suzuki T, Shizawa S, Kato K, Nagura H. Transforming growth factor and epidermal growth factor receptor expression in normal and diseased human adrenal cortex by immunohistochemistry and in situ hybridization. Modern Pathol 1994; 7: 741-746
34. Komminoth P, Roth J, Schroder S, Saremaslani P, Heitz PU. Overlapping expression of immunohistochemical markers and synaptophysin mRNA in pheochromocytomas and adrenocortical carcinomas. Implications for the differential diagnosis of adrenal gland tumors. Lab Invest 1995; 72: 424-431
35. Stratakis CA, Carney JA, Kirschner LS et al. Synaptophysin immunoreactivity in primary pigmented nodular adrenocortical disease: neuroendocrine properties of tumors associated with Carney complex. J Clin Endocrinol Metab 1999; 84: 1122-1128
36. Clouston WM, Cannell GC, Fryar BG, Searle JW, Martin NI, Mortimer RH. Virilizing adrenal adenoma in an adult with the Beckwith-Wiedemann syndrome: paradoxical response to dexamethasone. Clin Endocrinol (Oxf) 1989; 31: 467-473
37. Stratakis CA, Kirschner LS. Clinical and genetic analysis of primary bilateral adrenal diseases (micro- and macronodular disease) leading to Cushing syndrome. Horm Metab Res 1998; 30: 456-463
38. Sarlis NJ, Chrousos GP, Doppman JL, Carney JA, Stratakis CA. Primary pigmented nodular adrenocortical disease: reevaluation of a patient with carney complex 27 years after unilateral adrenalectomy. J Clin Endocrinol Metab 1997; 82: 1274-1278
39. Renshaw AA, Granter SR. A comparison of A103 and inhibin reactivity in adrenal cortical tumors: distinction from hepatocellular carcinoma and renal tumors. Mod Pathol 1998; 11: 1160-1164
40. Longui CA et al. Inhibin a-subunit (INHA) gene and locus changes in paediatric adrenocortical tumours from TP53 R337H mutation heterozygote carriers. J Med Genet 2004; 41: 354-359
41. Pelkey TJ, Frierson HF, Mills SE et al. The alpha subunit of inhibin in adrenal cortical neoplasia. Mod Pathol 1998; 11: 516-524
42. Henry I, Grandjouan S, Couillin P et al. Tumor-specific loss of 11p15.5 alleles in del11p13 Wilms tumor and in familial adrenocortical carcinoma. Proc Natl Acad Sci USA 1989; 86: 3247-3251
43. Henry I, Jeanpierre M, Couillin P et al. Molecular definition of the 11p15.5 region involved in Beckwith-Wiedemann syndrome and probably in predisposition to adrenocortical carcinoma. Hum Genet 1989; 81: 273-277
44. Yano T, Linehan M, Anglard P et al. Genetic changes in human adrenocortical carcinomas. J Natl Cancer Inst 1989; 81: 518-523
45. Gicquel C, Raffin-Sanson ML, Gaston V et al. Structural and functional abnormalities at 11p15 are associated with the malignant phenotype in sporadic adrenocortical tumors: study on a series of 82 tumors. J Clin Endocrinol Metab 1997; 82: 2559-2565
46. Malkin D, Li FP, Strong LC et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990; 250: 1233-1238
47. Kleihues P, Schauble B, zur Hausen A, Esteve J, Ohgaki H. Tumors associated with p53 germline mutations: a synopsis of 91 families. Am J Pathol 1997; 150: 1-13
48. Sameshima Y, Tsunematsu Y, Watanabe S et al. Detection of novel germ-line p53 mutations in diverse-cancer-prone families identified by selecting patients with childhood adrenocortical carcinoma. J Natl Cancer Inst 1992; 84: 703-707
49. Reincke M, Karl M, Travis WH et al. p53 mutations in human adrenocortical neoplasms: immunohistochemical and molecular studies. J Clin Endocrinol Metab 1994; 78: 790-794
50. Ohgaki H, Kleihues P, Heitz PU. p53 mutations in sporadic adrenocortical tumors. Int J Cancer 1993; 54: 408-410
51. Wagner J, Portwine C, Rabin K, Leclerc JM, Narod SA, Malkin D. High frequency of germline p53 mutations in childhood adrenocortical cancer. J Natl Cancer Inst 1994; 86: 1707-1710
52. Lin SR, Lee YJ, Tsai JH. Mutations of the p53 gene in human functional adrenal neoplasms. J Clin Endocrinol Metab 1994; 78: 483-491
53. Kjellman M, Roshani L, Teh BT et al. Genotyping of adrenocortical tumors: very frequent deletions of the MEN1 locus in 11q13 and of a 1-centimorgan region in 2p16. J Clin Endocrinol Metab 1999; 84: 730-735
54. Kjellman M, Kallioniemi OP, Karhu R et al. Genetic aberrations in adrenocortical tumors detected using comparative genomic hybridization correlate with tumor size and malignancy. Cancer Res 1996; 56: 4219-4223
55. Figueiredo BC, Stratakis CA, Sandrini R et al. Comparative genomic hybridization analysis of adrenocortical tumors of childhood. J Clin Endocrinol Metab 1999; 84: 1116-1121
56. Moul JW, Bishoff JT, Theune SM, Chang EH. Absent ras gene mutations in human adrenal cortical neoplasms and pheochromocytomas. J Urol 1993; 149: 1389-1394
57. Horvath A et al. A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia. Nat Genet 2006; 38: 794-800
58. Stratakis CA,, Chrousos GP. Cushing syndrome and disease. In: "Saunder's manual of pediatric practice." Finberg L (ed). Philadelphia: Saunders, 1998; 807-809
59. Stratakis CA, Chrousos GP. Carney complex and the familial lentiginosis syndromes: link to inherited neoplasias and developmental disorders and genetic loci. In: Proceedings of the 6th International Workshop on Multiple Endocrine Neoplasias. Utrect, Holland, June 1997. J Intern Med 1998; 243: 573-579
60. Bourdeau I, Stratakis CA. Cyclic AMP-dependent signaling aberrations in macronodular adrenal disease. Ann N Y Acad Sci 2002; 968: 240-255
61. Fragoso MC et al. Cushing's syndrome secondary to adrenocorticotropin-independent macronodular adrenocortical hyperplasia due to activating mutations of GNAS1 gene. J Clin Endocrinol Metab 2003; 88: 2147-2151
62. Stratakis CA. Genetics of adrenocortical tumors: gatekeepers, landscapes and conductors in symphony. Trends Endocrinol Metab 2003; 14: 404-410
63. Carney JA, Gordon H, Carpenter PC, Shenoy BV, Go VLW. The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine (Baltimore) 1985; 64: 270-283
64. Carney JA, Hruska LS, Beauchamp GD, Gordon H. Dominant inheritance of the complex of myxomas, spotty pigmentation and endocrine overactivity. Mayo Clin Proc 1986; 61: 165-172
65. Carney JA, Young WF. Primary pigmented nodular adrenocortical disease and its associated conditions. Endocrinologist 1992; 2: 6-21
66. Atherton DJ, Pitcher DW, Wells RS, Macdonald DM. A syndrome of various cutaneous pigmented lesions, myxoid neurofibromata and atrial myxoma: the NAME syndrome. Br J Dermatol 1980; 103: 421-429
67. Rhodes AR, Silverman RA, Harrist TJ, Perez-Atayde AR. Mucocutaneous lentigines, cardiomucocutaneous myxomas, and multiple blue nevi: The "LAMB" syndrome. J Am Acad Dermatol 1984; 10: 72-82
68. Doppman JL, Travis WD, Nieman L, Miller DL, Chrousos GP, Gomez TM. Cushing syndrome due to primary pigmented nodular adrenocortical disease: findings at CT and MR imaging. Radiology 1989; 172: 415-420
69. Mellinger RC, Smith RW. Studies of the adrenal hyperfunction in 2 patients with atypical Cushing's syndrome. J Clin Endocrinol Metab 1955; 16: 350-366
70. Kracht J, Tamm J. Bilaterale kleinknotige Adenomatose der Nebennierenrinde bei Cushing-Syndrom [Bilateral small-nodule adenomatosis of the adrenal cortex in Cushing Syndrom). Virchows Arch 1960; 333: 1-9
71. Levin ME. The development of bilateral adenomatous adrenal hyperplasia in a case of Cushing's syndrome of eighteen years' duration. Am J Med 1966; 40: 318-324
72. De Moor P, Roels H, Delaere K, Crabbe J. Unusual case of adrenocortical hyperfunction. J Clin Endocrinol Metab 1965; 25: 612-620
73. Gomez-Muguruza MT, Chrousos GP. Periodic Cushing's syndrome in a short boy: usefulness of the ovine corticotropin releasing hormone test. J Pediatr 1989; 115: 270-273
74. Sarlis NJ, Papanicolaou DA, Chrousos GP,, Stratakis CA. Paradoxical increase of urinary free cortisol and 17-hydroxy-steroids to dexamethasone during Liddle's test: a diagnostic test for primary pigmented adrenocortical disease. [Abstract P2-76]. In: Proceedings of the 79th Annual Meeting of the Endocrine Society in Minneapolis. MN, Bethesda: Endocrine Society Press, 1997;303
75. Caticha O, Odell WD, Wilson DE, Dowdell LA, Noth RH, Swislocki ALM. Estradiol stimulates cortisol production by adrenal cells in estrogen-dependent primary adrenocortical nodular dysplasia. J Clin Endocrinol Metab 1993; 77: 494-497
76. Stratakis CA, Carney JA, Lin J-P, Papanicolaou DA, Karl M, Kastner DL, Pras E, Chrousos GP. Carney complex, a familial multiple neoplasia and lentiginosis syndrome: analysis of 11 kindreds and linkage to the short arm of chromosome 2. J Clin Invest. 1996; 97: 699-705
77. Carney JA. Differences between nonfamilial and familial cardiac myxoma. Am J Surg Pathol 1985; 9: 53-55
78. Kennedy RH, Flanagan JC, Eagle RC, Jr, Carney JA. The Carney complex with ocular signs suggestive of cardiac myxoma. Am J Ophthalmol 1991; 111: 699-702
79. Ferreiro JA, Carney JA. Myxomas of the external ear and their significance. Am J Surg Pathol 1994; 18: 274-280
80. Carney JA, Toorkey BC. Myxoid fibroadenoma and allied conditions (myxomatosis) of the breast. A heritable disorder with special associations including cardiac and cutaneous myxomas. Am J Surg Pathol 1991; 15: 713-721
81. Courcoutsakis NA, Chow CK, Shawker T, Carney JA, Stratakis CA. Breast imaging findings in the complex of myxomas, spotty pigmentation, endocrine veractivity, and schwannomas (Carney complex). Radiology 1997; 205: 221-227
82. Carney JA, Ferreiro JA. The epithelioid blue nevus. A multicentric familial tumor with important associations, including cardiac myxoma and psammomatous melanotic schwannoma. Am J Surg Pathol 1996; 20: 259-272
83. Carney JA. Carney complex: the complex of myxomas, spotty pigmentation, endocrine veractivity, and schwannomas. Semin Dermatol 1995; 14: 90-98
84. Premkumar A, Stratakis CA, Shawker TH, Papanicolaou DA, Chrousos GP. Testicular ultrasound in Carney complex. J Clin Ultrasound 1997; 25: 211-214
85. Carney JA. Psammomatous melanotic schwannoma. A distinctive, heritable tumor with special associations, including cardiac myxoma and the Cushing syndrome. Am J Surg Pathol 1990; 14: 206-222
86. Carney JA, Toorkey BC. Ductal adenoma of the breast with tubular futures. A probable component of the complex of myxomas, spotty pigmentation, endocrine overactivity, and schwannomas. Am J Surg Pathol 1991; 15: 722-731
87. Carney JA, Stratakis CA. Ductal adenoma of the breast [letter]. Am J Surg Pathol 1996; 20: 1154-1155
88. Stratakis CA, Courcoutsakis N, Abati A, Filie A, Doppman JL, Carney JA et al. Thyroid gland abnormalities in patients with the "syndrome of spotty skin pigmentation, myxomas, and endocrine overactivity" (Carney complex). J Clin Endocrinol Metab 1997; 82: 2037-2043
89. Stratakis CA, Pras E, Tsigos C, Karl M, Papanicolaou DA, Kastner DL et al. Genetics of Carney complex: parent of origin effects and putative non-Mendelian features in an autosomal dominant disorder; absence of common defects of the ACTH receptor and RET genes. Abstract], Pediatr Res 1995; 37: 99A
90. Kirschner LS et al. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat Genet 2000; 26: 89-92
91. Gunther DF et al. Cyclical Cushing syndrome presenting in infancy: an early form of primary pigmented nodular adrenocortical disease, or a new entity? J Clin Endocrinol Metab 2004; 89: 3173-3182
92. Fragoso MC et al. Cushing's syndrome secondary to adrenocorticotropin-independent macronodular adrenocortical hyperplasia due to activating mutations of GNAS1 gene. J Clin Endocrinol Metab 2003; 88: 2147-2151
93. Groussin L et al. Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease. J Clin Endocrinol Metab 2002; 87: 4324-4329
94. Kirschner LS et al. Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the Carney complex. Hum Mol Genet 2000; 9: 3037-3046
95. D'Andrea MR et al. Expression of PDE11A in normal and malignant human tissues. J Histochem Cytochem 2005; 53: 895-903
96. Yuasa K et al. Genomic organization of the human phosphodiesterase PDE11A gene. Evolutionary relatedness with other PDEs containing GAF domains. Eur J Biochem 2001; 268: 168-178
97. Horvath A, Giatzakis C et al. Adrenal hyperplasia and adenomas are associated with inhibition of phosphodiesterase 11A in carriers of PDE11A sequence variants that are frequent in the population. Cancer Res 2006; 66: 11571-11575